0001209191-18-049972.txt : 20180906 0001209191-18-049972.hdr.sgml : 20180906 20180906202027 ACCESSION NUMBER: 0001209191-18-049972 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180806 FILED AS OF DATE: 20180906 DATE AS OF CHANGE: 20180906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLD DANIEL P PHD CENTRAL INDEX KEY: 0001288233 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 181058747 MAIL ADDRESS: STREET 1: 10445 PACIFIC CENTER CT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTER DRIVE STREET 2: SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-792-6300 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTER DRIVE STREET 2: SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2018-08-06 2018-08-08 0 0001262104 MEI Pharma, Inc. MEIP 0001288233 GOLD DANIEL P PHD C/O MEI PHARMA, INC. 3611 VALLEY CENTRE DRIVE, SUITE 500 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Common Stock 2018-08-06 4 F 0 50938 3.75 D 322882 D Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018. The number of shares withheld by and surrendered to the Issuer was incorrectly reported as 54,093 in the original filing of the Form 4 to which this amendment relates. Such number of shares withheld was overstated by 3,155 shares. The number of shares beneficially owned was incorrectly understated by 3,155 shares in the original filing of the Form 4 to which this amendment relates as a result of the incorrect reporting of the number of shares withheld described in Note 1 above. /s/ Brian G. Drazba, as attorney-in-fact 2018-09-06